CIBRA Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
CIBRA Capital's CPRX Position: Q3 2026 in Review
CIBRA Capital sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 99,250 shares — an estimated $3.12M sold.
CIBRA Capital first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $3.12M in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- CIBRA Capital reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- CIBRA Capital sold 99,250 Catalyst Pharmaceutical shares in Q3 2026, an estimated $3.12M.
- CIBRA Capital first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
- CIBRA Capital's Catalyst Pharmaceutical position peaked at $3.12M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on CIBRA Capital's 13F filing for Q3 2026, filed 19 Nov 2026.